American Rebel Expands
American Rebel Holdings, Inc. (NASDAQ: AREB) shares flat Wednesday, as the company behind American Rebel Light Beer today announced a new distribution partnership with Budweiser of Asheville, Inc. This agreement expands American Rebel Light Beer’s presence into Western North Carolina, a region known for its strong beer culture and community connection. The partnership reflects American Rebel Beverages ongoing strategy to align with established distributors who share their commitment to quality, authenticity, and growth.For nearly six decades, Budweiser of Asheville, Inc. has been a pillar of Western North Carolina’s beverage landscape. Founded in 1967 and independently owned by the Wood family since 1985, this Anheuser-Busch wholesaler has grown into a regional powerhouse. Budweiser of Asheville, Inc. distributes to a 12-county area that includes Asheville, Hendersonville, and Waynesville. With a reputation for unparalleled service and deep market knowledge, Budweiser of Asheville, Inc. has earned its place as a trusted partner to some of the world’s most iconic beverage brands. “While its portfolio is anchored by Anheuser-Busch giants like Budweiser and Michelob,” read this morning’s news release, “Budweiser of Asheville, Inc. has also evolved to embrace local craft beers, which now account for a meaningful portion of its business. This includes beloved North Carolina names like Asheville Brewing Co., Green Man Brewing, Nantahala Brewing Co., and Bold Rock Hard Cider.” Shares in AREB doffed four cents, or 3.5%, to $1.10.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


